APA (7th ed.) Citation

G, G., I, M., M, V., JP, O., MI, D., PCA, R., . . . AP, C. (2025). Enfortumab vedotin-related skin toxicities in patients with urothelial carcinoma: A systematic review and meta-analysis. Urologic oncology, 43(10), 595.e1-595.e11. https://doi.org/10.1016/j.urolonc.2025.05.016

Chicago Style (17th ed.) Citation

G, Gazzoni, et al. "Enfortumab Vedotin-related Skin Toxicities in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis." Urologic Oncology 43, no. 10 (2025): 595.e1-595.e11. https://doi.org/10.1016/j.urolonc.2025.05.016.

MLA (9th ed.) Citation

G, Gazzoni, et al. "Enfortumab Vedotin-related Skin Toxicities in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis." Urologic Oncology, vol. 43, no. 10, 2025, pp. 595.e1-595.e11, https://doi.org/10.1016/j.urolonc.2025.05.016.